Hirai M - Search Results

1

Inactivation of p16/CDKN2 and p15/MTS2 genes in different histological types and clinical stages of primary ovarian tumors.

Ichikawa Y, Yoshida S, Koyama Y, Hirai M, Ishikawa T, Nishida M, Tsunoda H, Kubo T, Miwa M, Uchida K. Ichikawa Y, et al. Among authors: hirai m. Int J Cancer. 1996 Dec 20;69(6):466-70. doi: 10.1002/(SICI)1097-0215(19961220)69:6<466::AID-IJC8>3.0.CO;2-2. Int J Cancer. 1996. PMID: 8980248

2

Inactivation of p16/CDKN2 and p15/MTS2 is associated with prognosis and response to chemotherapy in ovarian cancer.

Kudoh K, Ichikawa Y, Yoshida S, Hirai M, Kikuchi Y, Nagata I, Miwa M, Uchida K. Kudoh K, et al. Among authors: hirai m. Int J Cancer. 2002 Jun 1;99(4):579-82. doi: 10.1002/ijc.10331. Int J Cancer. 2002. PMID: 11992549

3

1q23 gain is associated with progressive neuroblastoma resistant to aggressive treatment.

Hirai M, Yoshida S, Kashiwagi H, Kawamura T, Ishikawa T, Kaneko M, Ohkawa H, Nakagawara A, Miwa M, Uchida K. Hirai M, et al. Genes Chromosomes Cancer. 1999 Jul;25(3):261-9. doi: 10.1002/(sici)1098-2264(199907)25:3<261::aid-gcc8>3.0.co;2-#. Genes Chromosomes Cancer. 1999. PMID: 10379872

4

Expression of alpha-fetoprotein and prostate-specific antigen genes in several tissues and detection of mRNAs in normal circulating blood by reverse transcriptase-polymerase chain reaction.

Ishikawa T, Kashiwagi H, Iwakami Y, Hirai M, Kawamura T, Aiyoshi Y, Yashiro T, Ami Y, Uchida K, Miwa M. Ishikawa T, et al. Among authors: hirai m. Jpn J Clin Oncol. 1998 Dec;28(12):723-8. doi: 10.1093/jjco/28.12.723. Jpn J Clin Oncol. 1998. PMID: 9879288

5

Gains of 1q21-q22 and 13q12-q14 are potential indicators for resistance to cisplatin-based chemotherapy in ovarian cancer patients.

Kudoh K, Takano M, Koshikawa T, Hirai M, Yoshida S, Mano Y, Yamamoto K, Ishii K, Kita T, Kikuchi Y, Nagata I, Miwa M, Uchida K. Kudoh K, et al. Among authors: hirai m. Clin Cancer Res. 1999 Sep;5(9):2526-31. Clin Cancer Res. 1999. PMID: 10499629

6

[Comparative genomic hybridization for analysis of chromosomal changes in cisplatin-resistant ovarian cancer].

Kudoh K, Takano M, Koshikawa T, Yoshida S, Hirai M, Kikuchi Y, Nagata I, Miwa M, Uchida K. Kudoh K, et al. Among authors: hirai m. Hum Cell. 2000 Sep;13(3):109-16. Hum Cell. 2000. PMID: 11197772 Japanese.

7

Prognostic factors relating to survival in uterine endometrioid carcinoma.

Hirai M, Hirono M, Oosaki T, Hayashi Y, Yoshihara T, Matsuzaki O. Hirai M, et al. Int J Gynaecol Obstet. 1999 Aug;66(2):155-62. doi: 10.1016/s0020-7292(99)00067-3. Int J Gynaecol Obstet. 1999. PMID: 10468339

8

Adjuvant chemotherapy in stage I uterine endometrial carcinoma.

Hirai M, Hirono M, Oosaki T, Hayashi Y, Yoshihara T, Itami M. Hirai M, et al. Int J Gynaecol Obstet. 2002 Jul;78(1):37-44. doi: 10.1016/s0020-7292(02)00069-3. Int J Gynaecol Obstet. 2002. PMID: 12113969

9

Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma.

Hirai M, Nakagawara A, Oosaki T, Hayashi Y, Hirono M, Yoshihara T. Hirai M, et al. Gynecol Oncol. 2001 Feb;80(2):181-8. doi: 10.1006/gyno.2000.6056. Gynecol Oncol. 2001. PMID: 11161857

10

[Clinical outcome of an anticancer agent screening test with primary culture cells].

Hirono M, Yoshihara T, Hayashi Y, Oosaki T, Hirai M. Hirono M, et al. Among authors: hirai m. Gan To Kagaku Ryoho. 1999 Sep;26(10):1449-58. Gan To Kagaku Ryoho. 1999. PMID: 10500533 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,432 results

Search Page

Filters